高级检索
当前位置: 首页 > 详情页

Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]“De Gasperis” Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy [2]Department of Health Sciences, University of Milano-Bicocca, Monza, Italy [3]Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China [4]Cardiopathology, Institute for Pathology, University Hospital of Tübingen, Tübingen, Germany [5]Sakakibara Heart Institute, Tokyo, Japan [6]Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan [7]Mais Philipps University of Marburg, Faculty of Medicine, Marburg, Germany [8]Henan Provincial People's Hospital, Zhengzhou, China [9]Department of Cardiology, Campus Virchow and Berlin Institute of Health, Center for Regenerative Therapies, Charité Universitätsmedizin, Berlin, Germany [10]Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA
出处:
ISSN:

关键词: Fulminant myocarditis Heart failure Endomyocardial biopsy Mechanical circulatory support COVID-19

摘要:
Fulminant myocarditis (FM) is a form of acute myocardial inflammation leading to rapid-onset hemodynamic instability due to cardiogenic shock or life-threatening arrhythmias. As highlighted by recent registries, FM is associated with high rates of death and heart transplantation, regardless of the underlying histology. Because of a paucity of evidence-based management strategies exists for this disease, an International workshop on FM was held in Wuhan, China, in October 2019, in order to share knowledge on the disease and identify areas of consensus. The present report highlights both agreements and controversies in FM management across the world, focusing the attention on areas of opportunity, FM definition, the use of endomyocardial biopsy and viral identification on heart specimens, treatment algorithms including immunosuppression and the timing of circulatory support escalation. This report incorporates the most recent recommendations from national and international professional societies. Main areas of interest and aims of future prospective observational registries and randomized controlled trials were finally identified and suggested. (C) 2020 Elsevier B.V. All rights reserved.

基金:

基金编号: 2019CR207

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统
最新[2025]版:
大类 | 2 区 医学
小类 | 3 区 心脏和心血管系统
JCR分区:
出版当年[2019]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]“De Gasperis” Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy [2]Department of Health Sciences, University of Milano-Bicocca, Monza, Italy
共同第一作者:
通讯作者:
通讯机构: [3]Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China [*1]“De Gasperis” Cardio Center,ASST Grande Ospedale Metropolitano Niguarda,Piazza Ospedale Maggiore,3; 20162,Milan,Italy. [*2]Division of Cardiology,Department of Internal Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science & Technology 1095# Jiefang Ave.,Wuhan 430030
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:2 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)